Back to search
X-Linked Retinitis Pigmentosa (XLRP)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which X-Linked Retinitis Pigmentosa (XLRP) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which X-Linked Retinitis Pigmentosa (XLRP) trials you may qualify forThe purpose of this Phase 2 Study is to see if the investigational study drug, laruparetigene zovaparvovec, also known as AGTC-501, given in both eyes, is safe…
InsightRP2 is a secure online patient registry specific to RP2-associated retinitis pigmentosa (RP). It is our goal to further the scientific understanding of t…
The aim of this study was to evaluate the safety, tolerability, and efficacy of one-time subretinal injection of FT-002 in male subjects (8-45 years of age) wit…
The purpose of this study is to assess the safety and tolerability of subretinal delivery of Adeno-associated Virus Vector (AAV5 hRKp.RPGR) gene therapy in adul…
This study will evaluate and compare the safety, efficacy, and tolerability of 2 doses of a recombinant adeno-associated virus vector (AGTC-501/laruparetigene z…